Web Analytics

3 Latest Announced Rounds

  • $5,500,000
    Unknown

    6 Investors

    Financial Services
    May 1st, 2025
  • $3,750,000
    Pre Series A

    3 Investors

    E-learning Providers
    May 1st, 2025
  • $7,300,000
    Seed

    3 Investors

    Financial Services
    May 1st, 2025
$1,436.14M Raised in 58 Funding Rounds in the past 7 Days - View All

Funding Round Profile

ExcepGen

start up
United States - San Francisco, CA
  • 25/08/2023
  • Unknown
  • $4,000,000

ExcepGen is a venture-backed, early stage biotechnology company located in San Francisco. The company is focused on solving fundamental underlying problems in drug discovery and applying those solutions to create a new generation of therapeutics.


Related People

Thomas FolliardCo Founder

Thomas Folliard United States - San Francisco, California

I am involved in a variety of activities and responsibilities having to do with making drugs easier to discover.

Specialties: foundational engineering of biology, next-generation drugs and drug discovery, starting organizations.